Analyst Ratings for Codiak Biosciences Inc. (CDAK)

CDAK Rating Summary

CDAK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CDAK
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $31.50 (+91.7%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/9/2020 Wedbush
» Updated 3/17/2021
David Nierengarten New Coverage Outperform
(N/A)
34.00
(31.00)
9.09
(16.43)
80.75% Details
11/9/2020 William Blair Matt Phipps New Coverage Outperform
(N/A)
N/A
(N/A)
9.09
(16.43)
80.75% Details
Like CDAK Ratings? Also take a look at SANA, EVLO, DNLI, FHTX

CDAK Ratings News